Over 44 Million Dollars Awarded in Medical Negligence Lawsuit for Missed Diagnosis of Adverse Reaction

Southfield, MI (Law Firm Newswire) June 9, 2016 – The University of Pennsylvania has to pay $44.1 million for misdiagnosing a bad reaction to anti-coagulant medication that resulted in a brain hemorrhage.

The verdict in this case found the attending physician to be 35 percent liable and the hospital 65 percent liable. The jury deliberated the case over a two-day period at the conclusion of the 13-day trial.

According to the documents submitted in the case, the hospital was negligent in recognizing the changes in 57-year-old Andrea Tate’s blood after being put on heparin. The plaintiff’s attorneys alleged that the changes were a significant indication that the patient was at high risk for a brain hemorrhage.

Tate had been hospitalized for a surgical procedure to remove a benign tumor (meningioma) on the tissue that covers the brain. Her subsequent tests showed revealed her INR moving from the low end of the normal spectrum to the higher end — from coagulation within 19 seconds to nearly 32 seconds. The patient had also been suffering from swelling and required an external ventricular drain.

Although the operation was referred to as a being routine, it actually resulted in a craniotomy and resection. The location and size of the tumor made the operation very complicated and difficult.

“For some unexplained reason, the hospital discontinued testing,” said Daren Monroe, Litigation Funding Corporation representative. “Three days later Tate was found comatose with a massive head bleed.”

The defendants countered the medical negligence lawsuit by suggesting the brain bleed was due to complications arising from the surgery.

Tate’s family filed a medical malpractice lawsuit citing negligence as the cause of death. They would have faced enormous medical expenses. “One way to handle those expenses would have been to apply for pre-settlement funding, also referred to as a lawsuit loan,” Monroe said. “Make sure to deal with an experienced lawsuit funding company.”

It is vitally important to deal with a lawsuit loan company that does not over-fund cases and has the sense of justice to offer compromised results should the case approved for pre-settlement funding does not do as well as expected. “Litigation funding corporation is one of the few companies that has the expertise and compassion to do just that,” Monroe said.

Learn more at http://www.litigationfundingcorp.com